Aids is curable?


Saturday, October 14, 2006

Cipla launches new anti-HIV drug Viraday

Pharma major Cipla today (12/10/06) launched its fixed dose single pill anti-HIV drug Viraday priced at Rs 5,200 a month.
Viraday is a combination of three anti-HIV drugs - Efavirenz 600 mg, Tenofovir 300 mg and Emtricitabine 200 mg, a company official said in New Delhi.
"We are offering the drug at Rs 5,200 a month, which is a fraction of the international price of approximately $1,100 (about Rs 52,800 a month)," he said.
While the company is introducing this drug in India for the first time, it is also looking at export opportunity, especially in Africa, the official said.


Post a Comment

<< Home